Stockscreener 앱 받기
4.27
0.00%
0.00
전일 마감가:
$4.27
열려 있는:
$4.29
하루 거래량:
3.81M
Relative Volume:
1.68
시가총액:
$510.83M
수익:
-
순이익/손실:
$-134.24M
주가수익비율:
-2.4124
EPS:
-1.77
순현금흐름:
$-121.34M
1주 성능:
+57.56%
1개월 성능:
+36.42%
6개월 성능:
+116.75%
1년 성능:
-17.41%
1일 변동 폭
$4.165
$4.415
1주일 범위
$2.67
$5.07
52주 변동 폭
$1.285
$5.66
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650) 822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
ANNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.27 | 636.47M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
Insider Stock Purchases: November 22, 2025 - Quiver Quantitative
Satter Muneer buys Annexon (ANNX) shares worth $3.6 million By Investing.com - Investing.com Nigeria
Satter Muneer buys Annexon (ANNX) shares worth $3.6 million - Investing.com
Annexon launches $75M public offering of common stock - MSN
Can Annexon Inc. stock beat analyst upgradesJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
How sentiment analysis helps forecast Annexon Inc.Weekly Profit Analysis & Community Verified Watchlist Alerts - newser.com
Annexon: Maintaining "Buy" Rating On Second C1q Inhibitor Advancement For Geographic Atrophy - Seeking Alpha
Wells Fargo Boosts Annexon’s Price Target Amid Optimism for Trial Success - StocksToTrade
Annexon Shares Rise After Director's $5.06 Million Stock Purchase - MarketScreener
Annexon stock rises after director purchases shares - MSN
Annexon stock rises after director purchases shares (ANNX:NASDAQ) - Seeking Alpha
Annexon Stock Surges on Positive Vonaprument Phase 3 Outlook - timothysykes.com
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed By Investing.com - Investing.com Australia
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed - Investing.com
Annexon, Inc. Stock (ANNX) Opinions on Recent Public Offering and Insider Purchase - Quiver Quantitative
Why analysts upgrade Annexon Inc. stockQuarterly Portfolio Report & AI Enhanced Execution Alerts - newser.com
Annexon Insider Bought Shares Worth $5,055,000, According to a Recent SEC Filing - MarketScreener
Satter Muneer a buys Annexon (ANNX) shares worth $5m By Investing.com - Investing.com UK
Satter Muneer a buys Annexon (ANNX) shares worth $5m - Investing.com India
Is Annexon Inc. stock positioned for long term growth2025 Short Interest & Comprehensive Market Scan Insights - newser.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Annexon (ANNX) Rating Maintained, Price Target Raised by Wells F - GuruFocus
Identifying reversal signals in Annexon Inc.Portfolio Update Summary & Proven Capital Preservation Methods - newser.com
Can Annexon Inc. stock deliver consistent earnings growth - newser.com
Key metrics from Annexon Inc.’s quarterly data2025 Performance Recap & Real-Time Volume Analysis - newser.com
Is Annexon Inc. stock a safe investment in uncertain marketsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
Annexon Inc. recovery potential after sell offTrade Analysis Report & Proven Capital Preservation Methods - newser.com
Is Annexon Inc a good long term investmentDividend Stability Analysis & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Annexon Inc. stock momentum explainedWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Will Annexon Inc. stock deliver better than expected guidanceEarnings Overview Summary & Weekly Watchlist for Consistent Profits - newser.com
Annexon Biosciences (ANNX) Gets a Buy from Bank of America Securities - The Globe and Mail
Is Annexon Inc. stock a buy for dividend growthWeekly Stock Report & Fast Moving Stock Watchlists - newser.com
What drives Annexon Inc stock priceMarket Sentiment Report & Create Passive Income With Smart Stocks - earlytimes.in
Annexon Biosciences Completes Successful Public Offering - MSN
Can momentum traders help lift Annexon Inc.2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Annexon raises $86.25 million in public offering of common stock By Investing.com - Investing.com Canada
ANNX News Today | Why did Annexon stock go up today? - MarketBeat
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):